2016
DOI: 10.1016/j.dld.2016.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
21
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 26 publications
(23 citation statements)
references
References 51 publications
1
21
0
1
Order By: Relevance
“…It has been revealed that there is a significant role of liver fibrosis on progression and metastasis of HCC, especially for patients who had comorbidity of HBV infection [20][21][22]. In the current study, we found the preoperative LSM value measured though FibroScan was an independent prognostic factor for HBV-related HCC patients.…”
Section: Discussionsupporting
confidence: 54%
“…It has been revealed that there is a significant role of liver fibrosis on progression and metastasis of HCC, especially for patients who had comorbidity of HBV infection [20][21][22]. In the current study, we found the preoperative LSM value measured though FibroScan was an independent prognostic factor for HBV-related HCC patients.…”
Section: Discussionsupporting
confidence: 54%
“…In the univariate analyses, the maximum tumor diameter, venous invasion, and MVD were determined as significant risk factors for lymph node metastasis in hindgut NET. The maximum tumor diameter and the presence of lymphovascular invasion are generally known as important predictive factors for any tumor [ 3 , 13 21 ]. However, results of our multivariate logistic regression analysis of lymph node metastasis revealed that the maximum tumor diameter alone was an independent predictor of lymph node metastasis, whereas lymphovascular invasion and MVD was not the predictor of lymph node metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…However, some authors have reported that these models are not very robust for evaluating liver fibrosis in HBV-positive patients [8]. Our previous study demonstrated that the accuracy of APRI and FIB-4 for predicting liver fibrosis related by HBV was moderate, which was different from the results of the original articles [9,10]. Another novel model was established based on 372 chronic HBV infection patients [11].…”
Section: Introductionmentioning
confidence: 94%